Likewise, changes in the melanopsin function were reported in neurological and psychiatric conditions including Parkinson’s disease (Joyce et al., 2018), multiple sclerosis (Meltzer et al., 2017), and depressive disorder (Feigl et al., 2018). The gene discussed is OPN4; the disease is Parkinson disease.